Accession Therapeutics Limited Revenue and Competitors
Estimated Revenue & Valuation
- Accession Therapeutics Limited's estimated annual revenue is currently $8.4M per year.
- Accession Therapeutics Limited's estimated revenue per employee is $155,000
- Accession Therapeutics Limited's total funding is $68M.
Employee Data
- Accession Therapeutics Limited has 54 Employees.
- Accession Therapeutics Limited grew their employee count by 6% last year.
Accession Therapeutics Limited's People
Name | Title | Email/Phone |
---|---|---|
1 | Founder and CEO | Reveal Email/Phone |
2 | CSO and Founder Trocept | Reveal Email/Phone |
3 | Chief Business Officer | Reveal Email/Phone |
4 | Chief Operating Officer | Reveal Email/Phone |
5 | CFO and Executive Chairman | Reveal Email/Phone |
6 | Head Translational Sciences | Reveal Email/Phone |
7 | Head CMC | Reveal Email/Phone |
8 | Head Quality & Strategy, Accession Executive Team | Reveal Email/Phone |
9 | Head Research, Accession Executive Team | Reveal Email/Phone |
10 | Associate Director - QA GCP | Reveal Email/Phone |
Accession Therapeutics Limited Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $99.4M | 458 | 40% | N/A | N/A |
#2 | $20.6M | 133 | 22% | N/A | N/A |
#3 | $156.1M | 146 | -70% | $145M | N/A |
#4 | $3.5M | 45 | -25% | $150M | N/A |
#5 | $1.6M | 21 | 0% | $459.5M | N/A |
#6 | $67.3M | 310 | 16% | $180.7M | N/A |
#7 | $8.5M | 55 | -2% | N/A | N/A |
#8 | $256.3M | 1025 | 9% | $168.5M | N/A |
#9 | $9.1M | 59 | -9% | N/A | N/A |
#10 | $16.6M | 107 | 3% | N/A | N/A |
What Is Accession Therapeutics Limited?
$68M
Total Funding
54
Number of Employees
$8.4M
Revenue (est)
6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $11.9M | 54 | 0% | N/A |
#2 | $7.6M | 54 | -2% | N/A |
#3 | $13.1M | 54 | -17% | N/A |
#4 | $12M | 54 | 0% | N/A |
#5 | $12.2M | 54 | 15% | N/A |